Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
Exocrine group:Aerosol inhalation of exosomes
Control group:Blank
Sponsors
Wuxi Fifth People's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients meet the diagnostic criteria "Diagnosis and treatment of novel coronavirus pneumonia (trial version fifth)"for suspected cases outside Hubei Province: combined with the following epidemiological and clinical manifestations: epidemiological history 1. Patients with travel or residence history in Wuhan and surrounding areas or other communities with case reports within 14 days before the onset of the disease; 2. Patients with a novel coronavirus infection (positive for nucleic acid detection) within 14 days before onset;, 3. Patients with fever or respiratory symptoms from Wuhan and surrounding areas or from the community with case report had been contacted within 14 days before the onset of the disease; 4. Clustering disease; clinical manifestations: (1) fever and / or respiratory symptoms; (2) having the above-mentioned imaging characteristics of pneumonia; (3) normal or reduced leukocyte count or lymphocyte count in the early stage of the disease. There is any one in the epidemiological history, and it is consistent with any two in the clinical manifestations. If there is no clear epidemiological history, it is in line with 3 of the clinical manifestations.
Exclusion criteria
Exclusion criteria: (1) Age 65; (2) Patients with severe heart, brain, lung, kidney dysfunction, endocrine disease, hematopoiesis system disease or other serious diseases and psychosis; (3) Pregnant and lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lung CT; | — |
Secondary
| Measure | Time frame |
|---|---|
| Nucleic acid detection of pharyngeal test;Leukocytes and lymphocytes in blood routine; | — |
Countries
China
Contacts
Public ContactMeiping Chu
Wuxi Fifth People's Hospital
Outcome results
None listed